Source: Cancer immunology immunotherapy. Unidade: FM
Subjects: LEUCEMIA MIELOIDE, CÉLULAS-TRONCO, INIBIDORES DE ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROVERSI, Fernanda Marconi et al. Novel inhibitor of hematopoietic cell kinase as a potential therapeutic agent for acute myeloid leukemia. Cancer immunology immunotherapy, v. 71, n. 8, p. 1909-1921, 2022Tradução . . Disponível em: https://doi.org/10.1007/s00262-021-03111-2. Acesso em: 01 nov. 2024.APA
Roversi, F. M., Bueno, M. L. P., Silva, J. A. F. da, Assis-Mendonca, G. R., Torello, C. O., Shiraishi, R. N., et al. (2022). Novel inhibitor of hematopoietic cell kinase as a potential therapeutic agent for acute myeloid leukemia. Cancer immunology immunotherapy, 71( 8), 1909-1921. doi:10.1007/s00262-021-03111-2NLM
Roversi FM, Bueno MLP, Silva JAF da, Assis-Mendonca GR, Torello CO, Shiraishi RN, Pericole FV, Ferro KP, Duarte ASS, Rego EM, Saad STO. Novel inhibitor of hematopoietic cell kinase as a potential therapeutic agent for acute myeloid leukemia [Internet]. Cancer immunology immunotherapy. 2022 ; 71( 8): 1909-1921.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1007/s00262-021-03111-2Vancouver
Roversi FM, Bueno MLP, Silva JAF da, Assis-Mendonca GR, Torello CO, Shiraishi RN, Pericole FV, Ferro KP, Duarte ASS, Rego EM, Saad STO. Novel inhibitor of hematopoietic cell kinase as a potential therapeutic agent for acute myeloid leukemia [Internet]. Cancer immunology immunotherapy. 2022 ; 71( 8): 1909-1921.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1007/s00262-021-03111-2